Did you know?
You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)
Re: Epigenetic Modifiers as Potential Therapeutic Targets in Diabetic Kidney Disease
"Could this explain why we have not seen the missing kidney data?"
No. Because the primary endpoint was not met, all secondary endpoint data could not be subject to formal statistical testing. But that didn't stop the company from presenting secondary MACE endpoints for the entire population, CKD group, and SGLT2 group, as well as cognition sub-study data. So no reason the kidney data couldn't be presented earlier.
